(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

122020016731

Em AnáliseUtility ModelPCT · US2017066562

Application data

Number

122020016731

Type

Utility Model

Filing

12/15/2017

Publication

-

PCT

US2017066562

Progress at the INPI

  1. Filing12/15/17
  2. Publication
  3. Examination
  4. Allowance03/15/22
  5. Grant05/10/22
  6. In force12/15/32

The patent was granted on 05/10/2022 and is in force until 12/15/2032. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:12/15/2032

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/13/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AFFERENT PHARMACEUTICALS INC.

US

Inventors

A. F. (pessoa física)

US

P. I. (pessoa física)

US

R. H. (pessoa física)

US

S. S. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/436,533 · 12/20/2016

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Alteração de sede deferida

#25.7

12/13/2022

RPI 2710

Concessão da patente

#16.1

Prazo de Validade: 20 (vinte) anos contados a partir de 15/12/2017, observadas as condições legais

05/10/2022

RPI 2679

Deferimento

#9.1

03/15/2022

RPI 2671

Conhecimento de parecer técnico

#7.1

10/26/2021

RPI 2651

Adição na publicação

#15.35

10/13/2021

RPI 2649

Não anuência — art. 229 da LPI

#7.5

08/17/2021

RPI 2641

Ciência (anuência ANVISA - art. 229-C)

#7.4

02/02/2021

RPI 2613

Notificação de pedido dividido

#2.4

10/27/2020

RPI 2599

Requerimento de pedido de patente

#2.10

Número de Protocolo '870200103037' em 17/08/2020 14:46 (WB)

08/25/2020

RPI 2590

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.